Iambic Therapeutics Announces Close of Oversubscribed $100 Million Series B Financing to Advance AI-Discovered Therapeutics into Clinical Development and Enters Collaboration with NVIDIA

BIOS Builders #23 with Tom Miller

Press

October 11, 2023

October 11, 2023

BIOS Builders #23 with Tom Miller

Press

MedCityNews: Already Partnered With Nvidia, Iambic Adds $100M for AI Drug Discovery

MedCityNews: Already Partnered With Nvidia, Iambic Adds $100M for AI Drug Discovery

Press

Fierce Biotech: Iambic Ups Rhythm in AI-enabled Race to Clinic, Revealing $100M Round and Nvidia Pact

Fierce Biotech: Iambic Ups Rhythm in AI-enabled Race to Clinic, Revealing $100M Round and Nvidia Pact

Announcements

Press

Iambic Therapeutics Announces Close of Oversubscribed $100 Million Series B Financing to Advance AI-Discovered Therapeutics into Clinical Development and Enters Collaboration with NVIDIA

Iambic Therapeutics Announces Close of Oversubscribed $100 Million Series B Financing to Advance AI-Discovered Therapeutics into Clinical Development and Enters Collaboration with NVIDIA

Press

Endpoints News: AI-driven biotech Iambic snags $100M to enter the clinic next year in HER2 field

Endpoints News: AI-driven biotech Iambic snags $100M to enter the clinic next year in HER2 field

Ascenta Investor Day: A Conversation with David M. Rubenstein and Tom Miller

Press

September 28, 2023

September 28, 2023

Ascenta Investor Day: A Conversation with David M. Rubenstein and Tom Miller

Entos (now Iambic) Included in Business Insider's List of Most-Promising Healthcare Start-Ups of 2023

Press

July 19, 2023

July 19, 2023

Entos (now Iambic) Included in Business Insider's List of Most-Promising Healthcare Start-Ups of 2023

NeuralPLexer: Multiscale generative diffusion with equivariant transformers

NVIDIA

Publications

April 19, 2023

April 19, 2023

NeuralPLexer: Multiscale generative diffusion with equivariant transformers

Announcements

Entos (Now Iambic) Presents Preclinical Data on its First Clinical Candidate

Entos (Now Iambic) Presents Preclinical Data on its First Clinical Candidate

Publications

A potent and highly selective irreversible HER2 inhibitor for treating HER2-driven cancers

A potent and highly selective irreversible HER2 inhibitor for treating HER2-driven cancers

Iambic Recruits Tom Daniel, M.D., to its Scientific Advisory Board

Announcements

April 7, 2023

April 7, 2023

Iambic Recruits Tom Daniel, M.D., to its Scientific Advisory Board

Tom Miller Presents at the NVIDIA Spring GTC23 Event

NVIDIA

Presentations

March 20, 2023

March 20, 2023

Tom Miller Presents at the NVIDIA Spring GTC23 Event

Iambic Recruits William Rastetter to Board and Announces Clinical Advisory Board

Announcements

March 16, 2023

March 16, 2023

Iambic Recruits William Rastetter to Board and Announces Clinical Advisory Board

Entos (Now Iambic) Presents Latest AI-Driven Drug Discovery Advances at NeurIPS 2022

Announcements

December 1, 2022

December 1, 2022

Entos (Now Iambic) Presents Latest AI-Driven Drug Discovery Advances at NeurIPS 2022

Entos (Now Iambic) Head of Business Development Mary Anderson Among Top 25 Healthcare Technology Leaders of San Diego for 2022

Announcements

Press

November 21, 2022

November 21, 2022

Entos (Now Iambic) Head of Business Development Mary Anderson Among Top 25 Healthcare Technology Leaders of San Diego for 2022

Freeflow Founders Session

Presentations

September 7, 2022

September 7, 2022

Freeflow Founders Session

Entos (Now Iambic) in Collaboration with Caltech and NVIDIA: Advances in geometric deep learning for computational chemistry in Proceedings of the National Academy of Science USA

NVIDIA

Publications

August 1, 2022

August 1, 2022

Entos (Now Iambic) in Collaboration with Caltech and NVIDIA: Advances in geometric deep learning for computational chemistry in Proceedings of the National Academy of Science USA

Chao Zhang joins Iambic as Chief Scientific Officer

Announcements

July 5, 2022

July 5, 2022

Chao Zhang joins Iambic as Chief Scientific Officer

Caltech Heritage Project: A profile on Tom Miller, CEO of Iambic

Presentations

June 1, 2022

June 1, 2022

Caltech Heritage Project: A profile on Tom Miller, CEO of Iambic

Entos (Now Iambic) Selected by Forbes for the AI50 List of Groundbreaking AI Companies

Press

Announcements

May 9, 2022

May 9, 2022

Entos (Now Iambic) Selected by Forbes for the AI50 List of Groundbreaking AI Companies

Iambic Appoints Nicholas A. Saccomano, Ph. D., to its Scientific Advisory Board

Announcements

February 4, 2022

February 4, 2022

Iambic Appoints Nicholas A. Saccomano, Ph. D., to its Scientific Advisory Board

Entos Mourns the Loss of Board Member Naren Gupta

Announcements

December 30, 2021

December 30, 2021

Entos Mourns the Loss of Board Member Naren Gupta

The Coronavirus in a Tiny Drop

Academic

Press

December 1, 2021

December 1, 2021

The Coronavirus in a Tiny Drop

Academic

Presentations

#COVIDisAirborne: Tom Miller presents Gordon Bell publication at SC21

#COVIDisAirborne: Tom Miller presents Gordon Bell publication at SC21

Presentations

Tom Miller Presents at PBSS Symposium 2021

Tom Miller Presents at PBSS Symposium 2021

#COVIDisAirborne: AI-enabled multiscale computational microscopy of delta SARS-CoV-2 in a respiratory aerosol

Academic

Publications

November 15, 2021

November 15, 2021

#COVIDisAirborne: AI-enabled multiscale computational microscopy of delta SARS-CoV-2 in a respiratory aerosol

NVIDIA

Press

Entos (Now Iambic) Transforms Drug Discovery With NVIDIA AI-Powered Molecular Simulation

Entos (Now Iambic) Transforms Drug Discovery With NVIDIA AI-Powered Molecular Simulation

NVIDIA

Press

Entos (Now Iambic) Transforms Drug Discovery and Design With NVIDIA AI-Powered Molecular Simulation

Entos (Now Iambic) Transforms Drug Discovery and Design With NVIDIA AI-Powered Molecular Simulation

Tom Miller Presents at the NVIDIA Fall GTC21 Event

NVIDIA

Presentations

November 1, 2021

November 1, 2021

Tom Miller Presents at the NVIDIA Fall GTC21 Event

UNiTE: Unitary N-body tensor equivariant network with applications to quantum chemistry

Publications

October 25, 2021

October 25, 2021

UNiTE: Unitary N-body tensor equivariant network with applications to quantum chemistry

Iambic Announces Scientific Advisory Board Additions

Announcements

September 9, 2021

September 9, 2021

Iambic Announces Scientific Advisory Board Additions

Iambic Raises $53 Million Series A Round Led by Coatue and Catalio

Announcements

July 14, 2021

July 14, 2021

Iambic Raises $53 Million Series A Round Led by Coatue and Catalio

OrbNet Denali: A machine learning potential for biological and organic chemistry with semi-empirical cost and DFT accuracy

Academic

Publications

July 5, 2021

July 5, 2021

OrbNet Denali: A machine learning potential for biological and organic chemistry with semi-empirical cost and DFT accuracy

NVIDIA

Presentations

Tom Miller Participates in NVIDIA Grand Challenge Panel During Spring GTC21

Tom Miller Participates in NVIDIA Grand Challenge Panel During Spring GTC21

NVIDIA

Presentations

Tom Miller Presents at the NVIDIA Spring GTC21 Event

Tom Miller Presents at the NVIDIA Spring GTC21 Event

Envision is Released Worldwide as Wallace Derricotte Joins Iambic to Lead Community Building

Schmidt Futures

Announcements

March 31, 2021

March 31, 2021

Envision is Released Worldwide as Wallace Derricotte Joins Iambic to Lead Community Building

Entos (Now Iambic) and Dow Sign Agreement to Develop Machine-Learning Platform for Catalyst Discovery

Announcements

March 1, 2021

March 1, 2021

Entos (Now Iambic) and Dow Sign Agreement to Develop Machine-Learning Platform for Catalyst Discovery

Entos (Now Iambic) to Develop Open-Source Machine-Learning Tool for Chemical Discovery

Announcements

November 30, 2020

November 30, 2020

Entos (Now Iambic) to Develop Open-Source Machine-Learning Tool for Chemical Discovery

Multi-Task Learning for Electronic Structure to Predict and Explore Molecular Potential Energy Surfaces

Academic

Publications

November 5, 2020

November 5, 2020

Multi-Task Learning for Electronic Structure to Predict and Explore Molecular Potential Energy Surfaces

OrbNet: Deep learning for quantum chemistry using symmetry-adapted atomic-orbital features

Academic

Publications

September 25, 2020

September 25, 2020

OrbNet: Deep learning for quantum chemistry using symmetry-adapted atomic-orbital features